Home/ Supplements/ Electrolytes/ Secretagogue Gold Orange

Secretagogue Gold Orange

product on market Powder MHP Maximum Human Performance Safety: 98/100
98/100

This product looks safe

  • Vitamin B6: 367mg is 3.7× the Tolerable Upper Intake Level (100mg)
  • 44% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

The profile consists primarily of essential electrolytes and Vitamin B1, which support cellular energy metabolism and fluid balance. Research provides strong evidence for the role of these nutrients in maintaining basic physiological functions. However, the overall evidence coverage for this specific formulation is very limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B6: 367mg is 3.7× the Tolerable Upper Intake Level (100mg)

Label

Product Label

Label for Secretagogue Gold Orange
Open Full PDF View on NIH DSLD →
Details

Label Data

15 Gram(s)
Serving Size
Other Combinations
Product Type
44%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
45 {Calories}
Sodium
55 mg (2% DV)
Potassium
200 mg (6% DV)
Total Carbohydrates
6 Gram(s) (2% DV)
0.5 mg (33% DV)
Within RDA (0.4× RDA) 76 studies (A:0, B:33)
6.6 mg (33% DV)
Within RDA (0.5× RDA) 196 studies (A:5, B:63)
367 mg (33% DV)
Exceeds UL by 3.7× (UL: 100 mg) 114 studies (A:3, B:35)
133 mcg (33% DV)
Within RDA (0.3× RDA) 226 studies (A:10, B:105)
2 mcg (33% DV)
Within RDA (0.8× RDA) 139 studies (A:1, B:44)
3.3 mg (33% DV)
Within RDA (0.7× RDA) 2 studies — no high-quality reviews
132 mg (33% DV)
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
0.67 mg (33% DV)
Within RDA (0.3× RDA) 9 studies — no high-quality reviews
5 mg (33% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
100 mcg (83% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
Polymer Transport Matrix
5900 mg
Secretagogue Augmenting Factors
5220 mg
Secretagogue Modulating Complex:
466 mg
Pituitary Support & IGF-1 Co-Factors
245 mg

Other Ingredients

Citric Acid Potassium Bicarbonate Sodium Bicarbonate Natural flavor Silica Acesulfame Potassium Beta-Carotene
Claims

Label Claims — Verification

Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Mix one packet in 5-6 oz of water and stir gently. Secretagogue-Gold(TM) is most effective when taken on an empty stomach, preferably 2-3 hours before or after a meal. For optimum results, Secretagogue-Gold(TM) should be taken every evening on an empty stomach before bed. Continue the use of Secretagogue-Gold(TM) for long-term benefits.

Warnings & Precautions

Keep out of reach of children.

Do not purchase if seal is broken.

Formulation Notes

dietary supplement

Additional Information

ADVANCED AGE MANAGEMENT SYSTEM

His many years of research and private practice have allowed Dr. Giampapa to develop this revolutionary natural approach to age management, which has become the core of his anti-aging program at the Giampapa Institute for Anti-Aging Medicine.

Protect from heat, light and moisture.

Store at 15-30(0)C (59-86(0)F).

Individual results vary.

99330012

RESTORE YOUR YOUTH GENERAL HEALTH AND WELL-BEING

30 PACKETS

naturally flavored

RECOMMENDED by THE INSTITUTE FOR ANTI-AGING MEDICINE DR. GIAMPAPA

Dr. Vincent C. Giampapa, MD is a world-renowned authority on anti-aging. He has more than 20 years of clinical practice working with his patients and is a founding member of the American Academy of Anti-Aging Medicine and chairman of the Annual International Conference of Anti-Aging Medicine. He is also a recipient of the prestigious Science and Technology award for the American Academy of Anti-Aging Medicine for his work in designing the computerized evaluation of biomarkers of aging.

Dr. Vincent C Giampapa, MD -Age Management Specialist -President of The Giampapa Institute for Anti-Aging Medicine -Co-Founder of The American Academy of Anti-Aging Medicine -Chief Scientific Advisor, MHP Inc.

Dr. Giampapa has also written numerous books on the topic of anti-aging, including Quantum Longevity, The Anti-Aging Solution and Breaking the Aging Code. Dr. Giampapa is president of the Giampapa Institute for Anti-Aging Medicine where he currently treats patients for age management.

Enclosed you will find Dr. Giampapa's Age Management System of diet and exercise recommendations to help you restore your youth, general health and well-being.

Metadata

Product Details

UPC / SKU6 66222 03200 9
DSLD Entry Date2014-05-23
Product TypeOther Combinations
FormPowder
DSLD ID32903
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.